S01E25 : METABOLIC MYTHS 2/3: JUICERO
The static is not empty. Decode the ledger of Metabolic Myths as we extract the Newtonian Force of Ego. The rot is in the roots of a $120M dead machine.
NOTES: Juicero: The Newtonian Force Of Ego
Juicero wasn't just a business failure; it was a $120M Britpop B-side of peak tech delusion. Why human hands beat Silicon Valley’s fear of the physical.
AUDIT: Juicero: The Spinach Kill Switch
Audit Juicero's $120M failure. Explore the Spinach Kill-Switch, Produce DRM, and how Perishable SaaS triggered the 2026 Right to Repair market correction.
S01E24 : COMPUTE SOVEREIGNTY 3/3: COREWEAVE/LAMBDA
“The isoelectric line is flat.” Telemetry from a melting edge node reveals the brutalist ROI of sovereign compute. The global cloud was a ghost story.
NOTES: Coreweave/Lambda: Hotel California in the Server Rack
Welcome to the AI Hotel California. Choking on Sedona humidity and lukewarm coffee while 80,000 H100s burn venture capital. The cloud is a locked cage.
AUDIT: CoreWeave / Lambda: Compute Sovereignty and the Brutalist ROI of Localized Silo
Audit the brutalist ROI of localized AI silos. From Schrems II compliance to the 40% utilization crisis and SIROF degradation. The global cloud is dead.
S01E23 : LUNAR LOGISTICS 3/3: ROCKET LAB/INTUITIVE
The cooling fans scream. We are the accountants of the apocalypse, auditing a collapse before the dust settles. The scrap value of the moon is negative.
NOTES: Rocket Lab/ Intuitive: The CapEx of Gravity
The Cislunar economy is a taxpayer-funded mirage. From leaky LUNR buckets to RKLB's lonely Time Lord CEO, here's how to get skint betting on a graveyard.
AUDIT: Rocket Lab / Intuitive: The Architecture of a Vacuum
An audit of the 2026 commercial space sector reveals a fragile cislunar monopsony masking insolvency. Discover the brutal CapEx of gravity and NSTM-3.
S01E22 : IN-VIVO GENE SURGERY 2/3: BEAM THERAPEUTICS
The file bled through the architecture. Act One of a systemic biotech collapse is written in the liver. Welcome to the Cassandra Protocol. Watch it burn.
AUDIT: Beam Therapeutics: The Clinical Dead Zone
A forensic audit of Beam Therapeutics (BEAM-302) reveals severe liver toxicity, a 12-month FDA hold, and executive de-risking in the gene surgery space.
NOTES: Beam Therapeutics: Editing The Ghost Engine
Beam Therapeutics is selling a gene-editing miracle, but with toxic livers and a CEO cashing out, the banana stand is burning. A brutal look at the spin.